id todo:paper_05315565_v44_n1-2_p34_DeNicola
record_format dspace
spelling todo:paper_05315565_v44_n1-2_p34_DeNicola2023-10-03T15:34:11Z Steroid protection in aging and age-associated diseases De Nicola, A.F. Pietranera, L. Beauquis, J. Ferrini, M.G. Saravia, F.E. Aging Arginine vasopressin Astrogliosis Diabetes mellitus Estradiol Hypertension Neurogenesis Neuroprotection argipressin corticosterone dexamethasone hydrocortisone mineralocorticoid receptor aging Alzheimer disease astrocytosis dentate gyrus hippocampus human hypertension nervous system development neuroprotection nonhuman priority journal short survey steroid metabolism streptozocin diabetes Adrenal Cortex Aged Aging Animals Diabetes Mellitus Estradiol Glucocorticoids Hippocampus Humans Hypertension Middle Aged Mineralocorticoids Neuroprotective Agents Rats Rats, Inbred Strains Animalia Mus Rattus Neuroactive steroids are secretory products of peripheral endocrine glands that modulate a variety of brain functions. A close relationship between neuroactive steroid structure and function becomes most evident under pathological circumstances. On one side, overproduction of glucocorticoid and mineralocorticoid neuroactive steroids may be detrimental to the hippocampus, which is enriched in glucocorticoid receptors (GR) and mineralocorticoid receptors (MR). Thus, a dysfunction of the adrenocortical system in aging and age-associated diseases (diabetes, hypertension) is able to cause hippocampal damage. Whereas aging and uncontrolled diabetes show a predominant GR overdrive, a MR overdrive characterizes hypertensive animals. Some abnormalities commonly found in the hippocampus of aging, diabetic and hypertensive animals include decreased neurogenesis, astrogliosis and neuronal loss in the hilus of the dentate gyrus (DG). On the other side, and in contrast to adrenal gland-derived steroids, estrogens qualify as hippocampal neuroprotectants. Given to middle-age mice, estrogens stimulated proliferation and differentiation of newborn cells in the DG, decreased astrogliosis and increased hilar neuronal number. Similar estrogen effects were obtained in mice with streptozotocin-induced diabetes and in spontaneously hypertensive rats (SHR). The results suggest that in aging and age-associated diseases, adrenocortical steroid overdrive sensitizes the hippocampus to the pathological milieu imposed by a pre-existing degeneration or illness. In this setting, estradiol neuroprotection rescues hippocampal parameters previously altered by the pathological environment. © 2008 Elsevier Inc. All rights reserved. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_05315565_v44_n1-2_p34_DeNicola
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Aging
Arginine vasopressin
Astrogliosis
Diabetes mellitus
Estradiol
Hypertension
Neurogenesis
Neuroprotection
argipressin
corticosterone
dexamethasone
hydrocortisone
mineralocorticoid receptor
aging
Alzheimer disease
astrocytosis
dentate gyrus
hippocampus
human
hypertension
nervous system development
neuroprotection
nonhuman
priority journal
short survey
steroid metabolism
streptozocin diabetes
Adrenal Cortex
Aged
Aging
Animals
Diabetes Mellitus
Estradiol
Glucocorticoids
Hippocampus
Humans
Hypertension
Middle Aged
Mineralocorticoids
Neuroprotective Agents
Rats
Rats, Inbred Strains
Animalia
Mus
Rattus
spellingShingle Aging
Arginine vasopressin
Astrogliosis
Diabetes mellitus
Estradiol
Hypertension
Neurogenesis
Neuroprotection
argipressin
corticosterone
dexamethasone
hydrocortisone
mineralocorticoid receptor
aging
Alzheimer disease
astrocytosis
dentate gyrus
hippocampus
human
hypertension
nervous system development
neuroprotection
nonhuman
priority journal
short survey
steroid metabolism
streptozocin diabetes
Adrenal Cortex
Aged
Aging
Animals
Diabetes Mellitus
Estradiol
Glucocorticoids
Hippocampus
Humans
Hypertension
Middle Aged
Mineralocorticoids
Neuroprotective Agents
Rats
Rats, Inbred Strains
Animalia
Mus
Rattus
De Nicola, A.F.
Pietranera, L.
Beauquis, J.
Ferrini, M.G.
Saravia, F.E.
Steroid protection in aging and age-associated diseases
topic_facet Aging
Arginine vasopressin
Astrogliosis
Diabetes mellitus
Estradiol
Hypertension
Neurogenesis
Neuroprotection
argipressin
corticosterone
dexamethasone
hydrocortisone
mineralocorticoid receptor
aging
Alzheimer disease
astrocytosis
dentate gyrus
hippocampus
human
hypertension
nervous system development
neuroprotection
nonhuman
priority journal
short survey
steroid metabolism
streptozocin diabetes
Adrenal Cortex
Aged
Aging
Animals
Diabetes Mellitus
Estradiol
Glucocorticoids
Hippocampus
Humans
Hypertension
Middle Aged
Mineralocorticoids
Neuroprotective Agents
Rats
Rats, Inbred Strains
Animalia
Mus
Rattus
description Neuroactive steroids are secretory products of peripheral endocrine glands that modulate a variety of brain functions. A close relationship between neuroactive steroid structure and function becomes most evident under pathological circumstances. On one side, overproduction of glucocorticoid and mineralocorticoid neuroactive steroids may be detrimental to the hippocampus, which is enriched in glucocorticoid receptors (GR) and mineralocorticoid receptors (MR). Thus, a dysfunction of the adrenocortical system in aging and age-associated diseases (diabetes, hypertension) is able to cause hippocampal damage. Whereas aging and uncontrolled diabetes show a predominant GR overdrive, a MR overdrive characterizes hypertensive animals. Some abnormalities commonly found in the hippocampus of aging, diabetic and hypertensive animals include decreased neurogenesis, astrogliosis and neuronal loss in the hilus of the dentate gyrus (DG). On the other side, and in contrast to adrenal gland-derived steroids, estrogens qualify as hippocampal neuroprotectants. Given to middle-age mice, estrogens stimulated proliferation and differentiation of newborn cells in the DG, decreased astrogliosis and increased hilar neuronal number. Similar estrogen effects were obtained in mice with streptozotocin-induced diabetes and in spontaneously hypertensive rats (SHR). The results suggest that in aging and age-associated diseases, adrenocortical steroid overdrive sensitizes the hippocampus to the pathological milieu imposed by a pre-existing degeneration or illness. In this setting, estradiol neuroprotection rescues hippocampal parameters previously altered by the pathological environment. © 2008 Elsevier Inc. All rights reserved.
format JOUR
author De Nicola, A.F.
Pietranera, L.
Beauquis, J.
Ferrini, M.G.
Saravia, F.E.
author_facet De Nicola, A.F.
Pietranera, L.
Beauquis, J.
Ferrini, M.G.
Saravia, F.E.
author_sort De Nicola, A.F.
title Steroid protection in aging and age-associated diseases
title_short Steroid protection in aging and age-associated diseases
title_full Steroid protection in aging and age-associated diseases
title_fullStr Steroid protection in aging and age-associated diseases
title_full_unstemmed Steroid protection in aging and age-associated diseases
title_sort steroid protection in aging and age-associated diseases
url http://hdl.handle.net/20.500.12110/paper_05315565_v44_n1-2_p34_DeNicola
work_keys_str_mv AT denicolaaf steroidprotectioninagingandageassociateddiseases
AT pietraneral steroidprotectioninagingandageassociateddiseases
AT beauquisj steroidprotectioninagingandageassociateddiseases
AT ferrinimg steroidprotectioninagingandageassociateddiseases
AT saraviafe steroidprotectioninagingandageassociateddiseases
_version_ 1807318755663937536